These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16504756)

  • 1. Timing of concurrent radiotherapy and chemotherapy in limited-disease small-cell lung cancer: "Meta-analysis of meta-analyses".
    Jeremic B
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):981-2. PubMed ID: 16504756
    [No Abstract]   [Full Text] [Related]  

  • 2. Concurrent versus sequential radiotherapy for small cell lung cancer.
    Tsukada H; Yokoyama A; Goto K; Takada M; Saijo N;
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):23-6. PubMed ID: 11479893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
    Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK;
    J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of radiotherapy for small-cell lung cancer.
    Lau J; Berlin J; Chalmers TC
    N Engl J Med; 1993 May; 328(19):1425-6. PubMed ID: 8386323
    [No Abstract]   [Full Text] [Related]  

  • 5. Limited small cell lung cancer--the role of radiotherapy.
    Turrisi AT
    Oncology (Williston Park); 1988 Jul; 2(7):19-25, 28-9, 32. PubMed ID: 2856316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer.
    De Ruysscher D; Pijls-Johannesma M; Bentzen SM; Minken A; Wanders R; Lutgens L; Hochstenbag M; Boersma L; Wouters B; Lammering G; Vansteenkiste J; Lambin P
    J Clin Oncol; 2006 Mar; 24(7):1057-63. PubMed ID: 16505424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined chemoradiotherapy in small cell lung cancer.
    Hahn NM; Hanna N
    Hematol Oncol Clin North Am; 2005 Apr; 19(2):321-42, vii. PubMed ID: 15833409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized phase 2 study of subcutaneous amifostine versus epoetin-alpha given 3 times weekly during concurrent chemotherapy and hyperfractionated radiotherapy for limited-disease small cell lung cancer.
    Han HS; Han JY; Yu SY; Pyo HR; Kim HY; Cho KH; Lee DH; Kim HT; Lee JS
    Cancer; 2008 Oct; 113(7):1623-31. PubMed ID: 18671241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of small cell lung cancer: limited diseases. Guidelines of clinical practice made by the European Lung Cancer Working Party].
    European Lung Cancer Working Party
    Rev Med Brux; 2008; 29(3):159-67. PubMed ID: 18705597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of radiotherapy in the management of patients with small cell lung cancer].
    Daveau C; Le Péchoux C; Besse B; Ferreira I; Amarouch A; Vicenzi L; Elloumi F; Roberti E; Bretel JJ
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S171-9. PubMed ID: 18235411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of radiation therapy in the treatment of small cell carcinoma of the lung--with a special reference to the optimal combination timing within chemotherapy and total radiation doses].
    Okazaki A; Sugiyama S; Noda M; Tanohata K; Maehara T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Mar; 47(3):479-87. PubMed ID: 3039457
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiation therapy and chemotherapy in the treatment of limited-disease small cell lung cancer.
    Jeremic B; Zimmermann FB; Bamberg M; Molls M
    Hematol Oncol Clin North Am; 2004 Apr; 18(2):343-53. PubMed ID: 15094175
    [No Abstract]   [Full Text] [Related]  

  • 13. Limited-stage small-cell lung cancer: the current status of combined-modality therapy.
    Socinski MA; Bogart JA
    J Clin Oncol; 2007 Sep; 25(26):4137-45. PubMed ID: 17827464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time factor in radiotherapy and chemotherapy for limited disease small-cell lung cancer.
    Nowara E; Suwinski R
    Cancer Invest; 2007; 25(3):163-71. PubMed ID: 17530486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
    Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
    J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiotherapy for lung cancer. Integration with chemotherapy].
    Moreno-Jiménez M; Aristu J
    Rev Med Univ Navarra; 2007; 51(4):13-33. PubMed ID: 18303657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent is the key: combined modality small-cell lung cancer.
    Livingston RB
    J Clin Oncol; 1998 Apr; 16(4):1631. PubMed ID: 9552077
    [No Abstract]   [Full Text] [Related]  

  • 18. Duration of chemotherapy for metastatic non-small-cell lung cancer: more may be not better.
    Sasse AD; Lima JP; Sasse EC; Santos LV
    J Clin Oncol; 2009 Dec; 27(35):e253; author reply e254. PubMed ID: 19884522
    [No Abstract]   [Full Text] [Related]  

  • 19. [Small cell lung cancer: therapeutic standard and prospects].
    Wolf M
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S20-4S26. PubMed ID: 15687989
    [No Abstract]   [Full Text] [Related]  

  • 20. [Limited forms of treatment for small-cell cancers].
    Perol M
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S147-9. PubMed ID: 10088296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.